Two Sigma Securities’s NovaBay Pharmaceuticals NBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.1K | Buy |
24,280
+6,807
| +39% | +$3.95K | ﹤0.01% | 1271 |
|
|
2025
Q1 | $10.2K | Sell |
17,473
-13,938
| -44% | -$8.15K | ﹤0.01% | 1221 |
|
|
2024
Q4 | $18.9K | Buy |
+31,411
| New | +$18.9K | ﹤0.01% | 1142 |
|
|
2024
Q2 | – | Sell |
-4,266
| Closed | -$15.6K | – | 1934 |
|
|
2024
Q1 | $15.6K | Buy |
4,266
+3,810
| +836% | +$14K | ﹤0.01% | 1200 |
|
|
2023
Q4 | $3.26K | Sell |
456
-335
| -42% | -$2.39K | ﹤0.01% | 1346 |
|
|
2023
Q3 | $12.5K | Buy |
+791
| New | +$12.5K | ﹤0.01% | 1121 |
|
|
2022
Q4 | – | Sell |
-12
| Closed | -$2K | – | 1787 |
|
|
2022
Q3 | $2K | Sell |
12
-17
| -59% | -$2.83K | ﹤0.01% | 1300 |
|
|
2022
Q2 | $9K | Buy |
+29
| New | +$9K | ﹤0.01% | 1109 |
|
|
2020
Q3 | – | Sell |
-10
| Closed | -$14K | – | 806 |
|
|
2020
Q2 | $14K | Buy |
+10
| New | +$14K | ﹤0.01% | 524 |
|
|
2019
Q3 | – | Sell |
-17
| Closed | -$34K | – | 1079 |
|
|
2019
Q2 | $34K | Buy |
+17
| New | +$34K | ﹤0.01% | 723 |
|
|
2015
Q4 | – | Hold |
0
| – | -$4K | – | 338 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 207 |
|